This post hoc analysis of the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment
Trial-1 (ACTT-1) shows a treatment effect of remdesivir (RDV) on progression to invasive …

Objective This living systematic review aims to provide a timely, rigorous and continuously
updated summary of the evidence available on the role of remdesivir in the treatment of …

Background The COVID-19 pandemic has stimulated worldwide investigation into a myriad
of potential therapeutic agents, including antivirals such as remdesivir. The first RCT …

Background Effective drug treatments for Covid-19 are needed to decrease morbidity and
mortality for the individual and to alleviate pressure on health care systems. Remdesivir …

There are multiple dimensions to consider when treating COVID-19: the severity of infection,
the goals of treatment, and the intervention being deployed. Most people with symptomatic …

Remdesivir, a direct-acting antiviral agent, may reduce mortality and progression to
mechanical ventilation in moderately ill patients hospitalized with COVID-19 on …

Background Real-world data on safety and clinical outcomes of remdesivir in COVID-19
management is scant. We present findings of data analysis conducted for assessing the …

Remdesivir was the first antiviral approved for treating COVID-19. We investigated its
patterns of use, effectiveness and safety in clinical practice in Greece. This is a retrospective …

Despite 2 years having passed since the start of the COVID-19 pandemic, there is still
intense debate about the best therapeutic strategy for patients with COVID-19. Multiple …

Remdesivir is one of few FDA-approved treatments for severe cases of Coronavirus Disease
2019 (COVID-19). To better assess its efficacy and safety, we conducted a meta-analysis to …